Mucosal Interleukin-6 Secretion in Ulcerative Colitis: Effects of Anti-Inflammatory Drugs and T-Cell Stimulation

References

• Lotz M, Jirik F, Kabouridis R, Tsoukas C, Hirano T, Kishimoto T, et al. B cell stimulating factor 2/IL-6 is a co-stimulant for human thymocytes and T lymphocytes. J Exp Med 1988; 167: 1253–8
   PubMed Web of Science ®Google Scholar
• Hirano T, Taga T, Nakano N, Yasukawa K, Kashiwamura S, Shimizu K, et al. Purification to homogenicity and characterization of human B-celi differentiation factor (BCDF or BSFp-2). Proc Natl Acad Sci USA 1985; 82: 549<M
   Google Scholar
• Borish L, Rosenbaum R, Albury L, Clark S. Activation of neutrophils by recombinant interleukin-6. Cell Immunol 1989; 121: 280–9
   PubMed Web of Science ®Google Scholar
• Salas M A., Evans S W., Levell M J., Whicher J T. Interleukin-6 and ACTH act synergistically to stimulate the release of corticosterone from adrenal glands. Clin Exp Immunol 1990; 79: 470–3
   PubMed Web of Science ®Google Scholar
• Aderka D, Le J, Vilcek J. IL-6 inhibits lipopolysaccharide-induced tumour necrosis factor production in cultured human monocytes, U937 cells and in mice. J Immunol 1989; 143: 3517–23
   PubMed Web of Science ®Google Scholar
• McGhee J R., Fujihashi K, Beagley K W., Kiyono H. Role of interleukin-6 in human and mouse mucosal IgA plasma cell responses. Immunol Res 1991; 10: 418–22
   PubMed Web of Science ®Google Scholar
• Castell J V., Andus T, Geiger T, Gomez-Lechon M J., David M, Klapproth J, et al. Interleukin-6 is the major regulator of acute phase protein synthesis in rat and in man. Adv Immuno-pharmacol 1988; 4: 191–201
   Google Scholar
• Lobo A J., Evans S W., Jones S C., Banks R, Rathbone B J., Axon A TR, et al. Plasma interleukin-6 in inflammatory bowel disease. Eur J Gastroenterol Hepatol 1992; 4: 367–72
   Web of Science ®Google Scholar
• Mahida Y R., Kurlac L, Gallagher A, Hawkey C J. High circulating levels of interleukin-6 in active Crohn's disease but not ulcerative colitis. Gut 1991; 32: 1531–4
   PubMed Web of Science ®Google Scholar
• Gross V, Andus T, Caesar I, Roth M, Scholmerich J. Evidence for continuous stimulation of interleukin-6 production in Crohn's disease. Gastroenterology 1992; 102: 514–9
   PubMed Web of Science ®Google Scholar
• Jones S C., Haidar A, Hagan P, Crabtree J E., Banks R E., Axon A TR, et al. Cytokine production in the mucosa of patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 1993; 5: 607–12
   Web of Science ®Google Scholar
• Hirano T, Akira S, Taga T, Kishimoto T. Biological and clinical aspects of interleukin-6. Immunol Today 1990; 11: 443–9
   PubMedGoogle Scholar
• Pallone F, Fais S, Squarcia O, Biancone L, Pozzilli P, Boirivant M. Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens. Gut 1987; 28: 745–53
   PubMed Web of Science ®Google Scholar
• Schreiber S, MacDermott R P., Raedler A, Pinnau R, Bertovich M J., Nash G S. Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease. Gastroenterology 1991; 101: 1020–30
   PubMed Web of Science ®Google Scholar
• Matsuura T, West G A., Youngman K R., Klein J S., Fiocchi C. Immune activation genes in inflammatory bowel disease. Gastroenterology 1993; 104: 448–58
   PubMed Web of Science ®Google Scholar
• da Cuncha Ferreira R., Forsyth L E., Richman P I., Wells C, Spencer J, MacDonald T T. Changes in the rate of crypt epithelial cell proliferation and mucosal morphology induced by a T-cell-mediated response in human small intestine. Gastroenterology 1990; 98: 1255–63
   PubMedGoogle Scholar
• MacDonald T T., Spencer J. Evidence that activated mucosal T cells play a role in the pathogenesis of enteropathy in human small intestine. J Exp Med 1988; 167: 1341–9
   PubMed Web of Science ®Google Scholar
• Eastwood G L., Trier J S. Organ culture of human rectal mucosa. Gastroenterology 1973; 64: 375–82
   PubMed Web of Science ®Google Scholar
• Crabtree J E., Heatley R V., Losowsky M S. Glycoprotein synthesis and secretion by cultured small intestinal mucosa in coeliac disease. Gut 1989; 30: 1339–43
   PubMedGoogle Scholar
• Crabtree J E., Heatley R V., Trejdosiewicz L K., Losowsky M S. T lymphocyte stimulation of human small intestinal glycoprotein biosynthesis: effects of anti-CD3 antibody on normal and coeliac mucosa. Int Arch Appl Immunol 1990; 93: 35–40
   PubMedGoogle Scholar
• Trejdosiewicz L K., Smart C J., Oakes D J., Howdle P D., Malizia G, Campana D, et al. Expression of T cell receptors TcRl (gamma/delta) and TcR2 (alpha/beta) in the human intestinal mucosa. Immunology 1989; 68: 7–12
   PubMed Web of Science ®Google Scholar
• Lauritsen K, Hansen J, Ryde M, Rask-Madsen J. Colonic azodisalicylate metabolism determined by in vivo dialysis in healthy volunteers and patients with ulcerative colitis. Gastroenterology 1984; 86: 1496–500
   PubMed Web of Science ®Google Scholar
• Therapeutic drugs, C Dollery. Churchill Livingstone, Edinburgh 1991; Vol 1: D44–50
   Google Scholar
• Alvan G, Orme M, Bertilsson L, Ekstrand R, Palmer L. Pharmacokinetics of indomethacin. Clin Pharmacol Ther 1975; 18: 364–73
   PubMed Web of Science ®Google Scholar
• Lin S N., Jessup K, Floyd M, Wang T-P F., Van Buren C T., Caprioli R M., et al. Quantitation of plasma azathioprine and 6-mercaptopurine levels in renal transplant patients. Transplantation 1980; 29: 290–4
   PubMed Web of Science ®Google Scholar
• Reed J C., Abidi A H., Alpers J D., Hoover R G., Robb R J., Nowell P C. Effect of cyclosporin A and dexamethasone on interleukin 2 gene receptor expression. J Immunol 1986; 137: 150–4
   PubMed Web of Science ®Google Scholar
• Mueller C M., Knoflach P, Zielinski C C. T cell activation in Crohn's disease. Gastroenterology 1990; 98: 639–46
   PubMed Web of Science ®Google Scholar
• Crabtree J E., Juby L D., Heatley R V., Lobo A J., Bullimore D W., Axon A TR. Soluble interleukin-2 receptor in Crohn's disease: relationship of serum levels to disease activity. Gut 1990; 31: 1033–6
   PubMed Web of Science ®Google Scholar
• McDonald G B., Jewell D P. Class II antigen (HLA-DR) expression by intestinal epithelial cells in inflammatory diseases of colon. J Clin Pathol 1987; 40: 312
   PubMedGoogle Scholar
• Selby W S., Janossy G, Mason D Y., Jewell D P. Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease. Clin Exp Immunol 1983; 53: 614
   PubMed Web of Science ®Google Scholar
• Kvale D, Brandtzaeg P, Lovhaug D. Up-regulation of the expression of secretory component and HLA molecules in a human colonic cell line by tumour necrosis factor-alpha and gamma interferon. Scand J Immunol 1988; 28: 351–7
   PubMed Web of Science ®Google Scholar
• Trejdosiewicz L K., Badr-el Din S, Smart C, Malizia G, Oakes D J., Heatley R V., et al. Colonic mucosal T lymphocytes in ulcerative colitis: expression of CD7 antigen in relation to MHC Class II (HLA-D) antigens. Dig Dis Sci 1989; 34: 1449–56
   PubMedGoogle Scholar
• Janossy G, Prentice H G. T cell subpopulations, monoclonal antibodies and their therapeutic applications. Clin Haematol 1982; 11: 631–60
   PubMedGoogle Scholar
• Janossy G, Bofill M, Trejdosiewicz L K., Willcox H NA, Chilosi M. Cellular differentiation of lymphoid subpopulations and their microenvironments in the human thymus. Curr Topics Pathol 1986; 75: 89–125
   PubMedGoogle Scholar
• Fiocchi C, Youngman K R., Yen-Lieberman B, Tubbs R R. Modulation of intestinal immune reactivity by interleukin 2. Dig Dis Sci 1988; 33: 1305–15
   PubMed Web of Science ®Google Scholar
• Choy M Y., Walker-Smith J A., Williams C B., MacDonald T T. Differential expression of CD25 (interleukin-2 receptor) on lamina propria T cells and macrophages in the intestinal lesions in Crohn's disease and ulcerative colitis. Gut 1990; 31: 1365–70
   PubMed Web of Science ®Google Scholar
• Breese E, Braegger C P., Corrigan C J., Walker-Smith J A., MacDonald T T. Interleukin-2 and interferon-y secreting γ cells in normal and diseased human intestinal mucosa. Immunology 1993; 78: 127–31
   PubMed Web of Science ®Google Scholar
• Mullin G E., Lazenby A J., Harris M L., Bayless T M., James S P. Increased interleukin-2 mRNA in the intestinal lesions of Crohn's disease but not ulcerative colitis. Gastroenterology 1992; 102: 1620
   PubMed Web of Science ®Google Scholar
• Mahida Y R., Wu K, Patel S, Jewell D P. Respiratory burst activity of intestinal macrophages in normal and inflammatory bowel disease. Gut 1989; 30: 1362–70
   PubMed Web of Science ®Google Scholar
• Mahida Y R., Wu K, Patel S, Jewell D P. Enhanced production of interleukin- β by mononuclear cells isolated from mucosa with active ulcerative colitis or Crohn's disease. Gut 1989; 30: 835–8
   PubMed Web of Science ®Google Scholar
• McGee D W., Aicher W K., Eldrige J H., Peppard J V., Mestecky J, McGhee J R. Transforming growth factor-beta enhances secretory component and major histocompatibility complex class 1 antigen expression on rat IEC-6 intestinal cell lines. Cytokine 1991; 3: 543–50
   PubMedGoogle Scholar
• Takizawa H, Ohtoshi T, Ohta K, Hirohata S, Yamaguchi M, Suzuki N, et al. Interleukin-6/B cell stimulatory factor-2 is expressed and released by normal and transformed human bronchial epithelial cells. Biochem Biophys Res Commun 1992; 187: 596–602
   PubMedGoogle Scholar
• Jones S C., Trejdosiewicz L K., Banks R E., Howdle P D., Axon A TR, Dixon M F., et al. IL-6 expression in intestinal enterocytes. J Clin Pathol 1993; 46: 1097–100
   PubMed Web of Science ®Google Scholar
• Mahida Y R., Lamming C ED, Gallagher A, Hawthorne A B., Hawkey C J. 5-Aminosalicylic acid is a potent inhibitor of interleukin-1 beta production in organ culture of biopsy specimens from patients with ulcerative colitis. Gut 1991; 32: 50-j
   Google Scholar
• Rachmilewitz D, Karmeli F, Schwartz L W., Simon P L. Effect of aminophenols (5-ASA and 4-ASA) on colonic interleukin-1 generation. Gut 1992; 33: 929–32
   PubMed Web of Science ®Google Scholar
• Crotty B, Jewell D P. Drug therapy of ulcerative colitis. Br J Clin Pharmacol 1992; 34: 189–98
   PubMed Web of Science ®Google Scholar
• Waage A, Slupphaug G, Shalaby R. Glucocorticoids inhibit the production of IL-6 from monocytes, endothelial cells and fibroblasts. Eur J Immunol 1990; 20: 2439–43
   PubMed Web of Science ®Google Scholar
• Gelfand E W., Cheung R K., Mills G B. The cyclosporins inhibit lymphocyte activation at more than one site. J Immunology 1987; 138: 1115–20
   PubMed Web of Science ®Google Scholar
• Lichtiger S, Present D H. Cyclosporine in treatment of severe active ulcerative colitis. Lancet 1990; 336: 16–9
   PubMed Web of Science ®Google Scholar
• Yoshimura N, Kahan B D., Oka T. The in vivo effect of cyclosporine on interleukin-6 gene expression in renal transplant recipients. Transplant Proc 1991; 23: 958–60
   PubMedGoogle Scholar
• Kozarek R A., Patterson D J., Gelfand M D., Botoman V A., Ball T J., Wilske K R. Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease. Ann Intern Med 1989; 110: 353–6
   PubMed Web of Science ®Google Scholar
• Asako H, Wolf R E., Granger N. Leukocyte adherence in rat mesenteric venules: effects of adenosine and methotrexate. Gastroenterology 1993; 104: 31–7
   PubMedGoogle Scholar
• Camperi M, Lanfranchi G A., Bazzocchi G, Brignola C, Benatti A, Boccia S, et al. Prostaglandins, indomethacin and ulcerative colitis. Gastroenterology 1980; 78: 193
   Google Scholar
• Rampton D S., Sladen G E. Relapse of ulcerative proctocolitis during treatment with non-steroidal anti-inflammatory drugs. Postgrad Med J 1981; 57: 297–9
   PubMed Web of Science ®Google Scholar